- Home
- BMA vs KRYS Comparison
BMA vs KRYS Comparison
Compare BMA & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMA
- KRYS
- Stock Information
- Founded
- BMA 1966
- KRYS 2015
- Country
- BMA Argentina
- KRYS United States
- Employees
- BMA N/A
- KRYS N/A
- Industry
- BMA Commercial Banks
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BMA Finance
- KRYS Health Care
- Exchange
- BMA Nasdaq
- KRYS Nasdaq
- Market Cap
- BMA 5.1B
- KRYS 4.8B
- IPO Year
- BMA 2006
- KRYS 2017
- Fundamental
- Price
- BMA $96.86
- KRYS $164.83
- Analyst Decision
- BMA Hold
- KRYS Strong Buy
- Analyst Count
- BMA 3
- KRYS 7
- Target Price
- BMA $50.83
- KRYS $206.67
- AVG Volume (30 Days)
- BMA 383.0K
- KRYS 309.7K
- Earning Date
- BMA 11-27-2024
- KRYS 11-04-2024
- Dividend Yield
- BMA 6.10%
- KRYS N/A
- EPS Growth
- BMA 471.05
- KRYS N/A
- EPS
- BMA 0.89
- KRYS 1.77
- Revenue
- BMA $2,808,783,625.00
- KRYS $241,519,000.00
- Revenue This Year
- BMA N/A
- KRYS $485.65
- Revenue Next Year
- BMA N/A
- KRYS $58.64
- P/E Ratio
- BMA $12.48
- KRYS $92.96
- Revenue Growth
- BMA 95.76
- KRYS 2722.80
- 52 Week Low
- BMA $24.41
- KRYS $107.50
- 52 Week High
- BMA $109.36
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- BMA 60.30
- KRYS 40.33
- Support Level
- BMA $83.12
- KRYS $155.16
- Resistance Level
- BMA $109.36
- KRYS $176.59
- Average True Range (ATR)
- BMA 5.94
- KRYS 9.47
- MACD
- BMA 0.74
- KRYS -2.78
- Stochastic Oscillator
- BMA 54.76
- KRYS 23.79
About BMA Banco Macro S.A. ADR (representing Ten Class B)
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.